Novavax Vaccine Found To Be Up To 90.4% Effective. CEO Says Company Plans To File For Authorization
Novavax, a small biotechnology company based in Maryland, announced on Monday that its Covid-19 vaccine was found to be safe and up to 90.4% effective in its Phase 3 clinical trial involving nearly 30...